Literature DB >> 18376466

[Discovery, clinical and etiological characteristic of hemorrhagic fever with renal syndrome in the subtropical zone of Krasnodar region].

T K Dzagurova, E A Tkachenko, Iu V Iunicheva, V G Morozov, A F Briukhanov, V N Bashkirtsev, N S Sedova, B Klempa, D Kruger.   

Abstract

Twenty-six patients with hemorrhagic fever with renal syndrome (HFRS) were revealed as a result of serological examination of 582 patients with fever living around Sochi town. Etiologic role of Dobrava virus subtype as the cause of HFRS was assessed by immunofluorescent and ELISA assays, and neutralization test. The principal host of this virus and source of infection for humans is Caucasian forest mouse Apodemus ponticus. HFRS morbidity was sporadic and not dependent from patients' occupation and season. Comparative analysis of clinical and laboratory data from HFRS cases caused by DOB/Sochi and DOB/Lipetsk subspecies, as well as Puumala virus showed higher proportion of severe forms of disease in patients with HFRS from Sochi.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18376466

Source DB:  PubMed          Journal:  Zh Mikrobiol Epidemiol Immunobiol        ISSN: 0372-9311


  2 in total

1.  Cytokine, Chemokine, and Metalloprotease Activation in the Serum of Patients with Nephropathia Epidemica from the Republic of Tatarstan and the Republic of Mordovia, Russia.

Authors:  Ekaterina Martynova; Yuriy Davidyuk; Emmanuel Kabwe; Ekaterina E Garanina; Venera Shakirova; Vera Pavelkina; Yulia Uskova; Robert J Stott; Toshana L Foster; Maria Markelova; Mehendi Goyal; Abhimat Gupta; Mannan Bhola; Vinay Kumar; Manoj Baranwal; Albert A Rizvanov; Svetlana F Khaiboullina
Journal:  Pathogens       Date:  2021-04-27

2.  Hemorrhagic Fever with Renal Syndrome, Russia.

Authors:  Evgeniy A Tkachenko; Aydar A Ishmukhametov; Tamara K Dzagurova; Alla D Bernshtein; Viacheslav G Morozov; Alexandra A Siniugina; Svetlana S Kurashova; Alexandra S Balkina; Petr E Tkachenko; Detlev H Kruger; Boris Klempa
Journal:  Emerg Infect Dis       Date:  2019-12       Impact factor: 6.883

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.